TMEM115

gene
On this page

Also known as PL6

Summary

TMEM115 (transmembrane protein 115, HGNC:30055) is a protein-coding gene on chromosome 3p21.31, encoding Transmembrane protein 115 (Q12893). May play a role in retrograde transport of proteins from the Golgi to the endoplasmic reticulum.

Enables identical protein binding activity. Involved in retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum. Located in Golgi cisterna membrane; Golgi transport complex; and nucleus.

Source: NCBI Gene 11070 — RefSeq curated summary.

At a glance

  • GWAS associations: 6
  • MANE Select transcript: NM_007024

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:30055
Approved symbolTMEM115
Nametransmembrane protein 115
Location3p21.31
Locus typegene with protein product
StatusApproved
AliasesPL6
Ensembl geneENSG00000126062
Ensembl biotypeprotein_coding
OMIM607069
Entrez11070

Gene structure

Transcript identifiers

Ensembl transcripts: 3 — 3 protein_coding

ENST00000266025, ENST00000901094, ENST00000972195

RefSeq mRNA: 1 — MANE Select: NM_007024 NM_007024

CCDS: CCDS2828

Canonical transcript exons

ENST00000266025 — 2 exons

ExonStartEnd
ENSE000008607525035821350359521
ENSE000010811455035475050355547

Expression profiles

Bgee: expression breadth ubiquitous, 281 present calls, max score 91.79.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 20.0013 / max 103.8190, expressed in 1813 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
4233719.25751813
423380.7439482

Top tissues by expression

298 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
stromal cell of endometriumCL:000225591.79gold quality
apex of heartUBERON:000209891.71gold quality
skin of legUBERON:000151191.54gold quality
left adrenal glandUBERON:000123490.91gold quality
right lobe of thyroid glandUBERON:000111990.88gold quality
mucosa of transverse colonUBERON:000499190.86gold quality
left lobe of thyroid glandUBERON:000112090.83gold quality
lower esophagus muscularis layerUBERON:003583390.80gold quality
skin of abdomenUBERON:000141690.78gold quality
lower esophagusUBERON:001347390.78gold quality
right adrenal glandUBERON:000123390.77gold quality
left adrenal gland cortexUBERON:003582590.77gold quality
right adrenal gland cortexUBERON:003582790.72gold quality
body of stomachUBERON:000116190.64gold quality
esophagogastric junction muscularis propriaUBERON:003584190.62gold quality
left coronary arteryUBERON:000162690.36gold quality
right coronary arteryUBERON:000162590.22gold quality
left uterine tubeUBERON:000130390.07gold quality
mucosa of stomachUBERON:000119990.01gold quality
muscle layer of sigmoid colonUBERON:003580589.96gold quality
coronary arteryUBERON:000162189.81gold quality
adrenal cortexUBERON:000123589.79gold quality
transverse colonUBERON:000115789.77gold quality
thoracic aortaUBERON:000151589.77gold quality
descending thoracic aortaUBERON:000234589.73gold quality
thyroid glandUBERON:000204689.72gold quality
ascending aortaUBERON:000149689.66gold quality
aortaUBERON:000094789.50gold quality
right atrium auricular regionUBERON:000663189.46gold quality
popliteal arteryUBERON:000225089.44gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes6.70

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): VHL

miRNA regulators (miRDB)

33 targeting TMEM115, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-7152-3P99.9767.47849
HSA-MIR-6721-5P99.9368.922981
HSA-MIR-449399.9066.48977
HSA-MIR-6780A-5P99.8866.692776
HSA-MIR-182-5P99.8774.032589
HSA-MIR-4728-5P99.8569.394718
HSA-MIR-6785-5P99.8268.684428
HSA-MIR-142-3P99.6271.30974
HSA-MIR-24-3P99.5969.971934
HSA-MIR-451B99.5568.281380
HSA-MIR-486-5P99.5170.39707
HSA-MIR-140-5P99.4467.20792
HSA-MIR-446099.3768.52615
HSA-MIR-361-3P99.1966.451381
HSA-MIR-427999.1966.702437
HSA-MIR-328-5P99.0864.651000
HSA-MIR-939-3P98.9765.072347
HSA-MIR-7851-3P98.7264.88980
HSA-MIR-6501-3P98.7167.451480
HSA-MIR-4700-5P98.6367.431915
HSA-MIR-427498.5966.10630
HSA-MIR-6742-3P97.9564.501490
HSA-MIR-203B-5P97.2468.54543
HSA-MIR-6718-5P97.2468.15553
HSA-MIR-410-5P96.5566.28459
HSA-MIR-323B-5P96.1266.39472
HSA-MIR-6726-5P95.9763.72841
HSA-MIR-92095.9763.95811
HSA-MIR-430095.8564.561003
HSA-MIR-5591-5P95.8564.761002

Literature-anchored findings (GeneRIF, showing 1)

  • Results establish that TMEM115 is an integral membrane protein of the Golgi stack regulating Golgi-to-ER retrograde transport and is likely to be part of the machinery of the COG complex. (PMID:24806965)

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
danio_reriotmem115ENSDARG00000055763
mus_musculusTmem115ENSMUSG00000010045
rattus_norvegicusTmem115ENSRNOG00000021899
drosophila_melanogasterCG9536FBGN0031818
caenorhabditis_elegansWBGENE00008687

Protein

Protein identifiers

Transmembrane protein 115Q12893 (reviewed: Q12893)

Alternative names: Placental protein 6, Protein PL6

All UniProt accessions (2): Q12893, A0A024R2Y2

UniProt curated annotations — full annotation on UniProt →

Function. May play a role in retrograde transport of proteins from the Golgi to the endoplasmic reticulum. May indirectly play a role in protein glycosylation in the Golgi.

Subunit / interactions. Homooligomer. Interacts with COPB1. May interact with LMAN1. Interacts with the COG complex; probably through COG3.

Subcellular location. Golgi apparatus. Golgi stack membrane.

Tissue specificity. Expressed strongly in kidney and skeletal muscle, followed by liver, placenta, pancreas, and lung, with low amounts in heart and only traces in brain. Widely expressed with ubiquitous expression in epithelial tissues (at protein level).

Similarity. Belongs to the TMEM115 family.

RefSeq proteins (1): NP_008955* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR013861TMEM115/Pdh1/Rbl19Family
IPR035952Rhomboid-like_sfHomologous_superfamily

Pfam: PF08551

UniProt features (14 total): topological domain 5, transmembrane region 4, region of interest 3, chain 1, modified residue 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q12893-F179.110.47

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (1): 329

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-6807878COPI-mediated anterograde transport

MSigDB gene sets: 122 (showing top): RRAGTTGT_UNKNOWN, GCAAGGA_MIR502, GOBP_VESICLE_MEDIATED_TRANSPORT, REACTOME_MEMBRANE_TRAFFICKING, GGAMTNNNNNTCCY_UNKNOWN, HESSON_TUMOR_SUPPRESSOR_CLUSTER_3P21_3, AACWWCAANK_UNKNOWN, IRF7_01, WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP, GRE_C, WANG_CISPLATIN_RESPONSE_AND_XPC_DN, LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN, CAAGGAT_MIR362, ACTWSNACTNY_UNKNOWN, GOCC_GOLGI_STACK

GO Biological Process (3): retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890), negative regulation of cell population proliferation (GO:0008285), protein transport (GO:0015031)

GO Molecular Function (2): identical protein binding (GO:0042802), protein binding (GO:0005515)

GO Cellular Component (6): Golgi membrane (GO:0000139), nucleus (GO:0005634), Golgi apparatus (GO:0005794), Golgi cisterna membrane (GO:0032580), membrane (GO:0016020), COG complex (GO:0017119)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
ER to Golgi Anterograde Transport1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
Golgi apparatus2
intracellular membrane-bounded organelle2
Golgi vesicle transport1
cell population proliferation1
regulation of cell population proliferation1
negative regulation of cellular process1
transport1
intracellular protein localization1
establishment of protein localization1
protein binding1
binding1
bounding membrane of organelle1
cytoplasm1
endomembrane system1
organelle membrane1
Golgi cisterna1
cellular anatomical structure1
vesicle tethering complex1

Protein interactions and networks

STRING

718 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
TMEM115UBAC2Q8NBM4494
TMEM115TMEM101Q96IK0472
TMEM115TMEM208Q9BTX3468
TMEM115TMEM59LQ9UK28445
TMEM115RHBDD2Q6NTF9411
TMEM115A0A1W2PP11A0A1W2PP11393
TMEM115CDKN2AP42771392
TMEM115PARLQ9H300391
TMEM115CYB561D2O14569384
TMEM115RHBDD3Q9Y3P4371
TMEM115RHBDF1Q96CC6370
TMEM115ZMYND10O75800369
TMEM115STX16O14662369
TMEM115RHBDL1O75783367
TMEM115RHBDF2Q6PJF5351

IntAct

69 interactions, top by confidence:

ABTypeScore
TMEM115SYNE4psi-mi:“MI:0915”(physical association)0.560
SYNE4TMEM115psi-mi:“MI:0915”(physical association)0.560
TMEM115AQP6psi-mi:“MI:0915”(physical association)0.560
TMEM115ASPGpsi-mi:“MI:0915”(physical association)0.560
TMEM115TMED8psi-mi:“MI:0915”(physical association)0.560
CYB5R3TMEM115psi-mi:“MI:0915”(physical association)0.560
TMEM115RABAC1psi-mi:“MI:0915”(physical association)0.560
TMEM115HTATIP2psi-mi:“MI:0915”(physical association)0.560
TMEM115MANBALpsi-mi:“MI:0915”(physical association)0.560
TMEM115TMX2psi-mi:“MI:0915”(physical association)0.560
TMEM115TLCD4psi-mi:“MI:0915”(physical association)0.560
TMEM115psi-mi:“MI:0915”(physical association)0.560
TMEM115LAMP2psi-mi:“MI:0915”(physical association)0.560
TMEM115SH3GLB1psi-mi:“MI:0915”(physical association)0.560
HTTTMEM115psi-mi:“MI:0915”(physical association)0.560
SCN3BABCC5psi-mi:“MI:0914”(association)0.530
SLC22A9GPR89Apsi-mi:“MI:0914”(association)0.530
SLC22A16APBA3psi-mi:“MI:0914”(association)0.530
NRASESYT2psi-mi:“MI:2364”(proximity)0.480

BioGRID (74): SYNE4 (Two-hybrid), TMEM115 (Two-hybrid), TMEM115 (Proximity Label-MS), TMEM115 (Proximity Label-MS), TMEM115 (Two-hybrid), TMEM115 (Affinity Capture-MS), TMEM115 (Affinity Capture-MS), TMEM115 (Affinity Capture-MS), TMEM115 (Proximity Label-MS), TMEM115 (Proximity Label-MS), TMEM115 (Affinity Capture-MS), TMEM115 (Proximity Label-MS), TMEM115 (Two-hybrid), TMEM115 (Two-hybrid), TMEM115 (Two-hybrid)

ESM2 similar proteins: A4FUB8, E9QBI7, O35394, O95070, O97681, P15920, P58872, P58873, Q0DWA9, Q0P5E4, Q12270, Q12893, Q13488, Q1RMH4, Q28C60, Q3UVK0, Q4V8F3, Q52NJ0, Q5RBS4, Q5XIT3, Q5Z413, Q6BSA9, Q6C741, Q6CDV6, Q6CR06, Q6DCK1, Q6FSG0, Q6P6G5, Q6UPR8, Q755H8, Q7Z2K6, Q874X5, Q8BHC7, Q8BXJ9, Q8RXQ2, Q8TEB9, Q8VC82, Q8VZ96, Q91VU1, Q91XB7

Diamond homologs: A4FUB8, Q12893, Q8LF05, Q9WUH1

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

0 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance0
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

482 predictions. Top by Δscore:

VariantEffectΔscore
3:50355545:TGC:Tacceptor_gain1.0000
3:50355545:TGCC:Tacceptor_loss1.0000
3:50355546:GCC:Gacceptor_loss1.0000
3:50355547:CCTGG:Cacceptor_loss1.0000
3:50355548:C:CAacceptor_loss1.0000
3:50355548:C:CCacceptor_gain1.0000
3:50355549:T:Gacceptor_loss1.0000
3:50355555:C:CTacceptor_gain1.0000
3:50355555:C:Tacceptor_gain1.0000
3:50355556:A:Tacceptor_gain1.0000
3:50358208:AGTAC:Adonor_loss1.0000
3:50358209:GTACC:Gdonor_loss1.0000
3:50358210:TAC:Tdonor_loss1.0000
3:50358211:A:AGdonor_loss1.0000
3:50358212:C:Adonor_loss1.0000
3:50358212:CCTT:Cdonor_gain1.0000
3:50355543:GTTGC:Gacceptor_gain0.9900
3:50355544:TTGC:Tacceptor_gain0.9900
3:50355546:GC:Gacceptor_gain0.9900
3:50355547:CC:Cacceptor_gain0.9900
3:50357266:A:Tacceptor_gain0.9900
3:50357391:C:CTdonor_gain0.9900
3:50357392:T:TTdonor_gain0.9900
3:50358461:A:Cdonor_gain0.9900
3:50355548:C:Tacceptor_gain0.9800
3:50356602:C:Adonor_gain0.9800
3:50358211:A:ACdonor_gain0.9800
3:50358212:C:CCdonor_gain0.9800
3:50357265:CAG:Cacceptor_gain0.9700
3:50358376:C:CTacceptor_gain0.9700

AlphaMissense

2238 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
3:50355527:A:GL291P0.999
3:50355527:A:TL291H0.999
3:50355536:A:GL288P0.999
3:50358255:A:GI270T0.999
3:50355515:A:GL295P0.998
3:50355539:G:TA287D0.998
3:50355547:C:AR284S0.998
3:50355547:C:GR284S0.998
3:50358219:C:GR282P0.998
3:50358255:A:TI270N0.998
3:50358443:G:CF207L0.998
3:50358443:G:TF207L0.998
3:50358445:A:GF207L0.998
3:50355542:A:GL286P0.997
3:50358213:C:AR284M0.997
3:50358213:C:GR284T0.997
3:50358255:A:CI270S0.997
3:50358461:A:CS201R0.997
3:50358461:A:TS201R0.997
3:50358463:T:GS201R0.997
3:50355531:C:GA290P0.996
3:50355540:C:TA287T0.996
3:50358215:T:AR283S0.996
3:50358215:T:GR283S0.996
3:50358261:A:GI268T0.996
3:50358886:A:GW60R0.996
3:50358886:A:TW60R0.996
3:50355518:C:GR294P0.995
3:50358216:C:GR283T0.995
3:50358460:A:GW202R0.995

dbSNP variants (sampled 300 via entrez): RS1000111239 (3:50359764 G>A), RS1000619900 (3:50360067 A>G), RS1001118108 (3:50361342 T>G), RS1002140246 (3:50360439 T>G), RS1002576811 (3:50355036 A>G), RS1002586670 (3:50355156 T>C), RS1003583860 (3:50356765 G>A), RS1003681720 (3:50356203 G>A,T), RS1004023337 (3:50355922 T>C), RS1004029001 (3:50356457 G>T), RS1004076448 (3:50356020 G>A), RS1004345617 (3:50359470 G>A), RS1004537271 (3:50355670 T>C), RS1004743833 (3:50359108 G>A,C), RS1005334242 (3:50360643 G>A)

Disease associations

OMIM: gene MIM:607069 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

6 associations (top):

StudyTraitp-value
GCST007559_24Sleep duration (short sleep)3.000000e-08
GCST010698_80Subcortical volume (min-P)3.000000e-24
GCST010699_110Brain morphology (min-P)4.000000e-08
GCST010701_52Cortical surface area (MOSTest)1.000000e-16
GCST010702_36Subcortical volume (MOSTest)1.000000e-10
GCST010703_262Brain morphology (MOSTest)2.000000e-13

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0004346neuroimaging measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

26 total (human), top 26 by PubMed support.

ChemicalActions (top 5)PubMed papers
Arsenicincreases abundance, increases expression, affects methylation, affects cotreatment2
Cyclosporinedecreases methylation, decreases expression2
aristolochic acid Iincreases expression1
FR900359increases phosphorylation1
bisphenol Fincreases expression, affects cotreatment1
triphenyl phosphateaffects expression1
pirinixic acidaffects binding, decreases expression, increases activity1
sodium arseniteaffects cotreatment, increases abundance, increases expression1
cobaltous chlorideincreases expression1
manganese chlorideaffects cotreatment, increases abundance, increases expression1
di-n-butylphosphoric acidaffects expression1
MT19c compounddecreases expression1
4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acidincreases expression1
Leflunomidedecreases expression1
Acetaminophenincreases expression1
Atrazinedecreases expression1
Benzo(a)pyreneaffects methylation, increases methylation1
Dexamethasoneaffects cotreatment, increases expression1
Indomethacinaffects cotreatment, increases expression1
Manganeseaffects cotreatment, increases abundance, increases expression1
Quercetinincreases phosphorylation1
Smokedecreases expression1
Tobacco Smoke Pollutionincreases expression1
Urethaneincreases expression1
1-Methyl-3-isobutylxanthineaffects cotreatment, increases expression1
Sodium Seleniteincreases expression1

Cellosaurus cell lines

1 cell lines: 1 transformed cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_C8A6HEK293 TMEM115-3xHA GolgiTAGTransformed cell lineFemale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.